To unravel the mechanism underlying the impact of GSK3β on MALT1 activity, CBM complex formation and NF-κB signalling in P/I stimulated Jurkat T-ALL cells, we focused on BCL10 as a potential GSK3β target. The gene discussed is MALT1; the disease is acute lymphoblastic leukemia.